Stock listing

Alnylam Pharmaceuticals, Inc.

Selected listing: 0HD2 · LSE · USD · GB

Alnylam Pharmaceuticals, Inc. (LSE:0HD2), Health Technology. Latest release Sep 29, 2026: AMVUTTRA® (vutrisiran) ‘Play by Play’ Initiative Highlights Former…

0HD2:LSEUSDGBUpdated October 2, 2026

Ticker: LSE:0HD2
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: USD

Latest news from Alnylam Pharmaceuticals, Inc.

AMVUTTRA® (vutrisiran) ‘Play by Play’ Initiative Highlights Former Athletes’ Stories to Shine a Light on the Often-Missed Signs of ATTR-CM

September 28, 2026

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings

August 30, 2026

Alnylam to Present New Data Reinforcing Strength in RNAi-Powered TTR Silencing and Continued Progress in Hypertension at ESC Congress 2026

August 24, 2026

Alnylam Pharmaceuticals Reports Second Quarter 2026 Financial Results and Highlights Recent Period Progress

July 30, 2026

Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

July 16, 2026

All Alnylam Pharmaceuticals, Inc. news →

Events

Replays

Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 08:30 AM ET
Watch
Alnylam Pharmaceuticals, Inc. (ALNY) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 08:30 AM ET
Watch
Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 08:30 AM ET
Watch

Research Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. company profile

View the public company page for Alnylam Pharmaceuticals, Inc. on 6ix.

Alnylam Pharmaceuticals, Inc. news

Read company news and market updates connected to Alnylam Pharmaceuticals, Inc..

Alnylam Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Alnylam Pharmaceuticals, Inc..